bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.02.03.636311

Predicting characterization of microbiome taxonomy from imaging using machine learning approaches

Abstract

AO_SCPLOWBSTRACTC_SCPLOWFor this study, a total of 47 mock human skin microbiome communities were created using microorganisms collected from human donors and grown in vitro for between eight and 32 days. Each mock community sample was split. Ten mL of each sample was used to determine the taxonomy of the community, using metatranscriptomics and Kraken2 to provide population-level taxonomic information; five mL of each sample was used for imaging. The resulting micrographs served as the basis for establishing a new analysis pipeline that sequentially used two different methods for machine learning and one statistical technique: (1) confocal microscopy images were segmented into individual cells using the generalist, deep learning, publicly available machine learning model Cellpose; (2) continuous probability density functions describing the joint distribution of the cell area and eccentricity were found using algorithms expressing the statistical technique of kernel density estimation; (3) these probability density functions were used as input for convolutional neural networks, that were trained to predict both the taxonomic diversity and the most common bacterial class, independently of metatranscriptomics. Specifically, models were made to predict the Shannon index (a quantitative measure of taxonomic diversity) and to predict the most common bacterial class, for each micrograph. Measured Shannon indices (based on metatranscriptomics) ranged from nearly 0 to 1.4. The model predictions of Shannon indices had a mean squared error of 0.0321 +/- 0.0035. The model predictions of the most common taxonomic class of bacteria had an accuracy of 94.0% +/- 0.7%. IO_SCPLOWMPORTANCEC_SCPLOWTaxonomic diversity is a useful metric for describing microbial communities and can be used as a measure of ecosystems health, resilience, and biological interactions. Characterization of microbial community diversity also has diagnostic applications. For the human skin microbiome in particular, microbial diversity directly impacts skin health, including resilience against pathogens and regulation of immune responses. Currently, microbial diversity can be determined either using traditional staining methods that are limited to pure cultures or using sequencing methods that require high investment in cost, time, and expertise. In this study, we demonstrate an innovative method that employs microscopy images of bacterial communities and machine learning to predict taxonomic diversity and the dominant bacterial classes of bacterial communities. The underlying framework of the pipeline for taxonomy prediction has the potential to be adapted and extended to other organisms and microbiomes and to make taxonomic analyses less expensive and more feasible in low-resource settings.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Niese, B., Sweet, P., Dinh, B. D., Scholes, A., LeSassier, D. S., Ternus, K., Contreras, L. M., Gordon, V.. 2025-02-03. Predicting characterization of microbiome taxonomy from imaging using machine learning approaches. https://doi.org/10.1101/2025.02.03.636311

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗